The Myomectomy Market is estimated at US$0.7 billion in 2026 and is projected to grow at a CAGR of 6.3% to reach US$1.1 billion by 2034.
Relevant uses and settings include hospital gynecology, fertility preserving surgery, minimally invasive procedures, specialty women’s health clinics, and postoperative recovery programs. Commercial considerations include procedure cost, surgeon skill variation, recurrence concerns, and decision complexity between surgical, pharmaceutical, and interventional alternatives.
This product will be delivered within 1-3 business days.
Market Overview
The Myomectomy Market covers surgical procedures, devices, and care pathways focused on removal of uterine fibroids while preserving the uterus in gynecologic treatment settings.Relevant uses and settings include hospital gynecology, fertility preserving surgery, minimally invasive procedures, specialty women’s health clinics, and postoperative recovery programs. Commercial considerations include procedure cost, surgeon skill variation, recurrence concerns, and decision complexity between surgical, pharmaceutical, and interventional alternatives.
Market Segmentation
By Procedure Type
- Abdominal (Open) Myomectomy
- Laparoscopic Myomectomy
- Hysteroscopic Myomectomy
- Robotic-Assisted Myomectomy
- Vaginal Myomectomy
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Specialty Fertility Centers
By Product
- Laparoscopic Power Morcellators
- Tissue Removal Systems (Hysteroscopic Morcellators)
- Energy & Sealing Devices
- Suturing & Closure Devices
- Imaging & Navigation Systems
- Ancillary Instruments & Consumables
Key Companies Analysed
- Johnson & Johnson MedTech
- Medtronic
- Intuitive Surgical
- Olympus
- Karl Storz
- Hologic
- CooperSurgical
- Stryker
- B. Braun
- Richard Wolf
- ConMed
- Boston Scientific
- Applied Medical
- Cook Medical
- Ethicon
- Laborie
- Microline Surgical
- Gynesonics
- LiNA Medical
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Myomectomy Market Overview
3. Myomectomy Market Dynamics
4. Myomectomy Market Strategic Analysis
5. Global Myomectomy Market Size, Share and Forecast, 2025-2034
6. North America Myomectomy Market Outlook to 2034
7. Europe Myomectomy Market Outlook to 2034
8. Asia-Pacific Myomectomy Market Outlook to 2034
9. Middle East and Africa Myomectomy Market Outlook to 2034
10. South and Central America Myomectomy Market Outlook to 2034
11. Myomectomy Market Competitive Landscape
12. Appendix
Companies Mentioned
- Johnson & Johnson MedTech
- Medtronic
- Intuitive Surgical
- Olympus
- Karl Storz
- Hologic
- CooperSurgical
- Stryker
- B. Braun
- Richard Wolf
- ConMed
- Boston Scientific
- Applied Medical
- Cook Medical
- Ethicon
- Laborie
- Microline Surgical
- Gynesonics
- LiNA Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 0.7 Billion |
| Forecasted Market Value ( USD | $ 1.1 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
